CN1444872A - Products using L-arginine as raw materials - Google Patents
Products using L-arginine as raw materials Download PDFInfo
- Publication number
- CN1444872A CN1444872A CN03109060A CN03109060A CN1444872A CN 1444872 A CN1444872 A CN 1444872A CN 03109060 A CN03109060 A CN 03109060A CN 03109060 A CN03109060 A CN 03109060A CN 1444872 A CN1444872 A CN 1444872A
- Authority
- CN
- China
- Prior art keywords
- arginine
- goods
- raw materials
- phosphatidylcholine
- procyanidin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
A health-care food in the form of table, powder, capsule, beverage, cake, or particle for treating hypertension, hyperlipemia, atheosclerosis, hepatism and nephrosis, improving immunity and sexual function, delaying sanility, and resisting oxidation is prepared from L-arginine, catalytic intensifying agent (phosphatidylcholine, proanthocyanidin, or cordyceptic polyose), and exipient (modified starch and/or edible cellulose or mixture).
Description
Technical field
The present invention relates to a kind of to the edible back of mammal goods with health role, particularly a kind of arginic goods of L-that contain.
Background technology
The L-arginine is the nutrient substance that extract from comprise nuts such as Semen sojae atricolor, Semen arachidis hypogaeae, Semen Juglandis, Semen Armeniacae Amarum, Semen coryli heterophyllae, it confirms by modern science to mammiferous Nutrition, blood fat reducing, blood pressure lowering, atherosclerosis, treatment hepatopathy, nephropathy, enhancing immunity, and improve the man, women's function aspects all has beneficial effect.But take this refinement material merely, produce a desired effect, need large dose oral administration.At present, seeking the arginic best compatibility material of L-, make the L-arginine can both inspire activity when any dosage is taken, strengthen its effect, strengthen its function and action intensity, is the difficult problem that scientist waits to study.
Summary of the invention
The invention provides a kind of is the goods of raw materials for production with the L-arginine, how solve makes the L-arginine inspire activity, strengthen its effect, strengthen the technical problem of its function and action intensity, reach the purpose that strengthens human immunocompetence, defying age, antioxidation, prevents and cures diseases.
The present invention is the technical scheme of the goods of raw materials for production with the L-arginine, it is characterized in that: contain L-arginine and at least a catalytic intensification agent, at least a solid agent in the goods, the arginic content of L-is 15-95%, and the catalytic intensification agent accounts for 5-85%, solid agent 0-20%.
Above-mentioned catalytic intensification agent is that phosphatidylcholine, procyanidin or Cordyceps polysaccharide select one or any two kinds and three kinds of raw material combination things.
Above-mentioned solid agent is that modified starch and dietary cellulose select one or mixture.
Said ratio is: L-arginine: 15-95%, phosphatidylcholine 1-50%, procyanidin 1-40%, Cordyceps polysaccharide 1-60%, solid agent 1-20%.
Above-mentioned L-arginine 15-95%, phosphatidylcholine 2-50%, procyanidin 3-35%.
Above-mentioned L-arginine 15-95%, Cordyceps polysaccharide 2-50%, procyanidin 3-35%.
Above-mentioned L-arginine 15-95%, phosphatidylcholine 1-45%, Cordyceps polysaccharide 1-40%.
Above-mentioned L-arginine 15-95%, phosphatidylcholine 5-85%.Above-mentioned L-arginine 15-95%, procyanidin 5-85%.
Above-mentioned L-arginine 15-95%, Cordyceps polysaccharide 5-85%.
Beneficial effect: the present invention by phosphatidylcholine, procyanidin and Cordyceps polysaccharide select one or mixture cooperate with L-is arginic, increased the supply of various enzymes such as nitric oxide, lipoxidase, NO-synthase, strengthened the effect of NO-synthase, quickened the transmission of nitric oxide in neurotransmitter, beyond thought synergism has taken place.Further the performance latter is in the effect of blood fat reducing, blood pressure lowering, atherosclerosis, treatment hepatopathy, nephropathy, enhancing immunity, defying age, aging resistance and improvement man, women's function aspects.Its key component L-arginine is nitric oxide production precursor, can increase intravital nitric oxide after taking, thereby reach above-mentioned effect.Phosphatidylcholine and procyanidin then can be strengthened the effect of nitricoxide synthase, thereby as a kind of catalytic intensification agent, increase nitric oxide production output quantity, strengthen the arginic effect of taking of L-.Cordyceps polysaccharide then itself promptly has above-mentioned functions, has quickened the transmission of nitric oxide in neurotransmitter, with the L-arginine from the same effect in different paths, thereby strengthen the effect of L-arginine aspect above-mentioned.
The L-arginine is a kind of semi-dispensable amino acid, and phosphatidylcholine, procyanidin and Cordyceps polysaccharide are some has exciting, strengthen the active material of L-arginine, play the catalytic intensification effect.L-arginine and its esters or bases be as one of raw material, by with phosphatidylcholine, procyanidin and Cordyceps polysaccharide select one or mixture cooperate, can have special nutrition or special treatment purposes.Can be used as the antidote and the liver function-promoter of ammonia intoxication hepatic coma, evident in efficacy to viral hepatitis, diseases such as intestinal ulcer, thrombosis, neurasthenia and male's azoospermia disease all there is therapeutic effect.In addition, arginine is a kind of important intermediate metabolites of organism ornithine cycle, is again the synthetic precursor substance of NO in the body.Clinical research shows, arginine mixes with phosphatidylcholine, procyanidin and Cordyceps polysaccharide, and oral, has resisting hypertension, anti peroxidation of lipid and improves the effect of hemorheology.Arginine also has the raising function of immune system, reduces effects such as postoperative infection complication, even effectively treats some cancer.
The present invention is the goods of raw material with the L-arginine, through with phosphatidylcholine, procyanidin and Cordyceps polysaccharide select one or mixture cooperate, strengthen the effect of nitricoxide synthase, increase nitric oxide production output quantity, quicken the transmission of nitric oxide in neurotransmitter, strengthened the arginic effect of taking of L-.Male, especially those people of a specified duration inadequately that erect that obstacle is arranged to sexual function.Therefore can promote blood flow to penis, make it more strong, can increase sperm number, can be used for treating male sterility.
The present invention is the goods of raw material with the L-arginine, warp and catalytic intensification agent, promptly with phosphatidylcholine, procyanidin and Cordyceps polysaccharide select one or mixture cooperate, the manufacturing of energy stimulating growth hormone, and growth hormone is fatty for eliminating, strong muscle is very useful, can increase muscle and reduce fat, impel patient and serious burn patient's wound to restore.
The present invention is the goods of raw material with the L-arginine, through with phosphatidylcholine, procyanidin and Cordyceps polysaccharide select one or mixture cooperates, the reinforcement nitricoxide synthase effect, increase nitric oxide production output quantity, can stimulate thymus, raise immunity.Thymus is the glandula that is positioned at the breastbone rear, the inside has stored important disease-resistant cell-T cell, can help the external infection of body resistance, can increase the quantity of T cell, make health more effectively keep out the detrimental microorganisms invasion, the natural killer cell line anticancer with the mankind's immunocyte co-manufactured human body can suppress the formation of multiple malignant tumor.The present invention is the goods of raw material with the L-arginine, through with phosphatidylcholine, procyanidin and Cordyceps polysaccharide select one or after mixture cooperates, caused the synergism that increases nitrogen oxide, increase and strengthened the precursor of the deutero-relaxing factor of skin, relaxing factor is that nitric oxide (NO) not only has intensive diastole effect, but also can suppress that PA is assembled, anti-mononuclear cell depends on chemotactic, resisting vascular smooth muscle hyperplasia, these all are formed with crucial effect to tremulous pulse medicated porridge sample.Add strongly reducing blood fat, blood pressure lowering, atherosclerosis, treatment hepatopathy, nephropathy, enhancing immunity, reach the function of improving man, women's function aspects.
The specific embodiment
Goods of the present invention are one of raw material with the L-arginine, through with phosphatidylcholine, procyanidin and Cordyceps polysaccharide select one or mixture cooperate, some flavoring agents, modified starch, dietary fiber solid agent can be added, the health care medicine or the health food of tablet, powder, capsule, beverage, cake class or granule shape can be manufactured.
The L-arginine can be natural arginine or synthetic arginine, can refine from nut, seeds such as beans, Semen arachidis hypogaeae, Semen Juglandis, Semen Armeniacae Amarum, Semen coryli heterophyllae, Semen Helianthi, Fructus anacardii, adds gelatin and makes; The effect of phosphatidylcholine is confirmed by science that it can extract from raw materials such as Semen sojae atricolor; Procyanidin has antioxidant activity and eliminates the effect of free radical, can extract from seeds such as Semen Vitis viniferae; The medical value of Cordyceps polysaccharide is confirmed by motherland's medical science that it can extract from the Chinese medicine Cordyceps, also can replace with other saccharide and replace.
It below is several embodiments of the present invention: L-arginine+phosphatidylcholine+procyanidin L-arginine+phosphatidylcholine+procyanidin+Cordyceps polysaccharide
15％ + 50％ + 35％ 15％ + 40％ + 30％ + 15％
20％ + 47％ + 33％ 20％ + 37％ + 27％ + 16％
25％ + 44％ + 31％ 25％ + 34％ + 24％ + 17％
30％ + 41％ + 29％ 30％ + 31％ + 21％ + 18％
35％ + 38％ + 27％ 35％ + 28％ + 18％ + 19％
40％ + 35％ + 25％ 40％ + 25％ + 15％ + 20％
45％ + 32％ + 23％ 45％ + 22％ + 12％ + 21％
50％ + 29％ + 21％ 50％ + 19％ + 12％ + 19％
55％ + 26％ + 19％ 55％ + 16％ + 10％ + 19％
60％ + 23％ + 17％ 60％ + 13％ + 8％ + 19％
65％ + 20％ + 15％ 65％ + 10％ + 15％ + 10％
70％ + 17％ + 13％ 70％ + 7％ + 8％ + 15％
75％ + 14％ + 11％ 75％ + 5％ + 10％ + 10％
80％ + 11％ + 9％ 80％ + 3％ + 7％ + 10％
85％ + 8％ + 7％ 85％ + 2％ + 5％ + 8％
90％ + 5％ + 5％ 90％ + 1％ + 4％ + 5％
95％ + 2％ + 3％ 95％ + 1％ + 2％ + 2％
L-arginine 15-95%, phosphatidylcholine 5-85%.
L-arginine 15-95%, procyanidin 5-85%.
L-arginine 15-95%, Cordyceps polysaccharide 5-85%.L-arginine+phosphatidylcholine+solid agent L-arginine+procyanidin+solid agent
30％ + 50％ + 20％ 40％ + 40％ + 20％
35％ + 48％ + 17％ 45％ + 40％ + 15％
40％ + 45％ + 15％ 50％ + 34％ + 16％
45％ + 50％ + 5％ 55％ + 30％ + 15％
50％ + 49％ + 1％ 60％ + 35％ + 5％
55％ + 40％ + 5％ 65％ + 25％ + 10％
60％ + 37％ + 3％ 70％ + 23％ + 7％
65％ + 30％ + 5％ 75％ + 20％ + 5％
70％ + 20％ + 10％ 80％ + 15％ + 5％
75％ + 10％ + 15％ 85％ + 3％ + 12％
80％ + 8％ + 12％ 90％ + 9％ + 1％
85％ + 7％ + 8％ 95％ + 4％ + 1％
90％ + 1％ + 9％
95%+4%+1%L-arginine+Cordyceps polysaccharide+solid agent L-arginine+Cordyceps polysaccharide+procyanidin
20％?+ 60％ + 20％ 15％?+ 50％ + 35％
25％ + 60％ + 15％ 20％ + 45％ + 35％
30％ + 58％ + 12％ 25％ + 45％ + 30％
35％ + 55％ + 12％ 30％ + 40％ + 30％
40％ + 50％ + 10％ 35％ + 40％ + 25％
45％ + 46％ + 9％ 40％ + 33％ + 27％
50％ + 42％ + 8％ 45％ + 30％ + 25％
55％ + 40％ + 5％ 50％ + 30％ + 20％
60％ + 30％ + 10％ 55％ + 25％ + 20％
65％ + 28％ + 7％ 60％ + 23％ + 17％
70％ + 25％ + 5％ 65％ + 20％ + 15％
75％ + 23％ + 2％ 70％ + 5％ + 25％
80％ + 19％ + 1％ 75％ + 10％ + 15％
85％ + 10％ + 5％ 80％ + 15％ + 5％
90％ + 6％ + 4％ 85％ + 5％ + 10％
95％ + 4％ + 1％ 90％ + 5％ + 5％
95%+2%+3%L-arginine+phosphatidylcholine+Cordyceps polysaccharide
15％?+ 50％ + 35％
20％?+ 47％ + 33％
25％?+ 44％ + 31％
30％?+ 41％ + 29％
35％?+ 38％ + 27％
40％?+ 35％ + 25％
45％?+ 32％ + 23％
50％?+ 29％ + 21％
55％?+ 26％ + 19％
60％?+ 23％ + 17％
65％?+ 20％ + 15％
70％?+ 17％ + 13％
75％?+ 14％ + 11％
80％?+ 11％ + 9％
85％?+ 8％ + 7％
90％?+ 5％ + 5％
95％?+ 2％ + 3％
Claims (10)
1, a kind of is the goods of raw materials for production with the L-arginine, it is characterized in that: contain L-arginine and at least a catalytic intensification agent, at least a solid agent in the goods, the arginic content of L-is 15-95%, and the catalytic intensification agent accounts for 5-85%, solid agent 0-20%.
2, according to claim 1 is the goods of raw materials for production with the L-arginine, it is characterized in that: described catalytic intensification agent is that phosphatidylcholine, procyanidin or Cordyceps polysaccharide select one or any two kinds and three kinds of raw material combination things.
3, according to claim 1 is the goods of raw materials for production with the L-arginine, it is characterized in that: described solid agent is that modified starch and dietary cellulose select one or mixture.
4, according to claim 1,2 or 3 described be the goods of raw materials for production with the L-arginine, it is characterized in that: described proportioning is: L-arginine: 15-95%, phosphatidylcholine 1-50%, procyanidin 1-40%, Cordyceps polysaccharide 1-60%, solid agent 1-20%.
5, according to claim 1,2 or 3 described be the goods of raw materials for production with the L-arginine, it is characterized in that: described L-arginine 15-95%, phosphatidylcholine 2-50%, procyanidin 3-35%.
6, according to claim 1,2 or 3 described be the goods of raw materials for production with the L-arginine, it is characterized in that: described L-arginine 15-95%, Cordyceps polysaccharide 2-50%, procyanidin 3-35%.
7, according to claim 1,2 or 3 described be the goods of raw materials for production with the L-arginine, it is characterized in that: described L-arginine 15-95%, phosphatidylcholine 1-45%, Cordyceps polysaccharide 1-40%.
8, according to claim 1,2 or 3 described be the goods of raw materials for production with the L-arginine, it is characterized in that: described L-arginine 15-95%, phosphatidylcholine 5-85%.
9, according to claim 1,2 or 3 described be the goods of raw materials for production with the L-arginine, it is characterized in that: described L-arginine 15-95%, procyanidin 5-85%.
10, according to claim 1,2 or 3 described be the goods of raw materials for production with the L-arginine, it is characterized in that: described L-arginine 15-95%, Cordyceps polysaccharide 5-85%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB031090605A CN1235577C (en) | 2003-04-03 | 2003-04-03 | Products using L-arginine as raw materials |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB031090605A CN1235577C (en) | 2003-04-03 | 2003-04-03 | Products using L-arginine as raw materials |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1444872A true CN1444872A (en) | 2003-10-01 |
| CN1235577C CN1235577C (en) | 2006-01-11 |
Family
ID=27814504
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB031090605A Expired - Fee Related CN1235577C (en) | 2003-04-03 | 2003-04-03 | Products using L-arginine as raw materials |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1235577C (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8945655B2 (en) | 2007-07-10 | 2015-02-03 | Conopco, Inc. | Stable and consumable compositions |
| CN107847476A (en) * | 2015-07-13 | 2018-03-27 | 协和发酵生化株式会社 | Containing the arginic tablet of high concentration |
-
2003
- 2003-04-03 CN CNB031090605A patent/CN1235577C/en not_active Expired - Fee Related
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8945655B2 (en) | 2007-07-10 | 2015-02-03 | Conopco, Inc. | Stable and consumable compositions |
| CN107847476A (en) * | 2015-07-13 | 2018-03-27 | 协和发酵生化株式会社 | Containing the arginic tablet of high concentration |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1235577C (en) | 2006-01-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1270622C (en) | Plant additive premixed forage for aquatic culture and bait therefrom | |
| CN1568196A (en) | Nutrient therapy for immuno-compromised patients | |
| CN100339023C (en) | Embryonic egg health-care food, and its making method | |
| CN106107463A (en) | Super Quinoa Antifatigue milk tea processing technology | |
| CN1966031A (en) | Medicament for preventing and treating ageing diseases | |
| CN1292756C (en) | Effervescence tablet preparation for replenishing nutritious elements to human being and its preparation method | |
| CN1235512C (en) | Health-care beverage papaya milk and its preparation method | |
| CN1620920A (en) | Composite fungi amylose nutrient | |
| US20080124318A1 (en) | Algae supplement and treatment method | |
| CN1235577C (en) | Products using L-arginine as raw materials | |
| CN105477100A (en) | Lucid ganoderma spore oil compound health care spray and preparation method | |
| CN1927059A (en) | Buccal tablets produced with peanut and red date, and method for making same | |
| CN1593191A (en) | Pollen, bee milk food and its preparation method | |
| CN1864545A (en) | Preparation of highland barley SOD an conditioning food containing highland barley SOD | |
| CN1813790A (en) | Tablet auxiliary product for increase of body immunological competence | |
| CN1174037A (en) | Monascus preparation for hyperlipemia and relevant cardiac and cerebral diseases | |
| CN105394750A (en) | Seabuckthorn seed oil compound functional health product | |
| CN1895293A (en) | Spirulina oral tablet for supplementing human-body nutrients and its preparation | |
| CN1628693A (en) | Glossy ganoderma preparation containing main active substance of glossy ganoderma herb and preparing method thereof | |
| CN1193769C (en) | Health-care food with sobering function | |
| CN106722971A (en) | Cultivate the spirulina fertilizer powder of rich selenium germanium health-care rice | |
| CN1611249A (en) | Antisenescent longevity powder | |
| CN1261103C (en) | Microbial drug material, its preparing method and usage | |
| CN103232931A (en) | Vitamin, microelement and pine pee series health-care snake medicinal liquor for prolonging life | |
| CN103948591B (en) | A kind of slimming agents |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |